Brief: Hansoh Pharmaceutical Reports Drug Registration Approval Of 5th Indication Of Ameile Granted By NMPA
08/01/2026 10:32
Jan 8 (Reuters) - Hansoh Pharmaceutical 3692.HK: DRUG REGISTRATION APPROVAL OF THE FIFTH INDICATION OF AMEILE GRANTED BY NMPA Further company coverage: 3692.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansoh Pharmaceutical
See all newsHansoh Pharmaceutical jumps most in 8 weeks on Roche tie-up
Deals of the day-Mergers and acquisitions
Factbox: Major drugmakers turn to China for licensing deals
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion (updated)
China's Hansoh Pharma strikes drug deal with Roche worth over $15 billion